Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-009299
Filing Date
2023-02-01
Accepted
2023-02-01 16:43:59
Documents
5
Effectiveness Date
2023-02-01

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm234461d1_s8.htm S-8 82279
2 EXHIBIT 5.1 tm234461d1_ex5-1.htm EX-5.1 6836
3 EXHIBIT 23.2 tm234461d1_ex23-2.htm EX-23.2 2481
4 EXHIBIT 23.3 tm234461d1_ex23-3.htm EX-23.3 18191
5 EX-FILING FEES tm234461d1_exfilingfees.htm EX-FILING FEES 34167
  Complete submission text file 0001104659-23-009299.txt   145167
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269511 | Film No.: 23577378
SIC: 2836 Biological Products, (No Diagnostic Substances)